Coronary atherosclerosis is known to be associated with cardiomyopathy in patients worldwide. Present ly there is a high prevalence of cardiovascular risk across the globe and the cost of heart disease treating is very high. Therefore, prevention of heart diseases has become the better or easier option. The aim of the present study was to evaluate the cardioprotective effects of Curcuma longa aqueous extract (AECL) in hypercholesterolaemic rats. To achieve this 40 rats were randomly devided into four groups with 10 rats per group. Rats from the group I (normal control) received no treatment. High cholesterol diet (2 g/kg, oral) and high dose of anti-thyroid hormone drug carbimazole (60 mg/kg, oral) were administered once daily for 8 weeks to induce hypercholesterolaemia in rats of II-IV groups. Group II served as toxic (negative) control and group III (positive control) was treated with a standard lipid-lowering drug atorvastatin (20 mg/kg, oral). Group IV received AECL (200 mg/kg) once daily for 8 weeks. For lipid profile analysis the total cholesterol, high density lipoprotein cholesterol, triglycerides levels were estimated and creatine kinase, lactate dehydrogenase and aspartate transminase activities as cardiac biomarkers were assayed in blood serum using standard methods. The histopathological analysis of the heart tissue was carried out. It was shown that AECL significantly reduced hyperlipidaemia, stabilized cardiac biochemical markers and protected the cardiac muscle fibers from injury. The results of the present study suggest that the Curcuma longa extract has cardioprotective potential, and can be used to prevent hypercholesterolaemia-induced myocardial injury. k e y w o r d s : ethnopharmacology, carbimazole, atorvastatin, hypercholesterolaemia, cardiomyopathy, cardioprotection, Curcuma longa. 
F or long, coronary heart disease (CHD) has continued to rank as number one cause of death in most Northern European, North American and other developed countries [1] . Athero sclerosisrelated cardiovascular diseases are also important. Hypercholesterolaemia and hyperlipidae mia, have long been associated with atherosclerosis [2, 3] , and are also known precursors of CHD [4] . Hypercholesterolaemia induces oxidative stress and causes vascular endothelial dysfunction, which may in turn intensify injury of cardiac muscle fibres [5] .
Uncontrolled abnormalities in serum lipids levels or dyslipidaemia have been implicated in the onset of CHDs. Lowering lipids and cholesterol levels by drug or dietary interventions could reduce the risk of CHD. Recently, there has been increased interest in research on natural products, with poten tials to lower blood cholesterol levels. Many herbal or plant products were reported to have a potential to reduce lipid and cholesterol in the body [2, 6] .
Turmeric (Curcuma longa), an annual plant, belongs to the ginger family of herbs, zingiberaceae. Its use in folklore medicine to treat numerous disea ses is well documented [7] . Nutrition interacts with organs in the body, in many ways and the possible effect of slowing down organ damage has been con sidered. Several studies have emphasized on the im portance of dietary composition in the treatment of diseases [8] .
Hypercholesterolaemic rats have been reported to develop systemic organ complications, including heart injury [6] . Thus investigation into the preven tion and treatment of abnormal cholesterol levels or heart injury complications, with a simple and common medicinal plant like Curcuma longa, is an important step in maintaining optimum health. To date, there is no literature on the effects of Turmeric against hypercholesterolaemiainduced cardiomyo pathy. The aim of this research was to evalua te the cardioprotective effects of aqueous extract of Curcuma longa in hypercholesterolaemic rats.
materials and methods
Turmeric. Fresh samples of Curcuma longa were obtained from local market in Enugu, Nigeria. The plant material was authenticated by a consultant taxonomist at the herbarium section of the Depart ment of Plant Science and Biotechnology, Univer sity of Nigeria, Nsukka, and a voucher specimen was deposited at the herbarium with reference number [UNH 205 C ] for future reference.
Aqueous extract of Curcuma longa (AECL). Preparation as described by Uchendu and Agu [9] was done, with slight modification. Briefly, hot-wa ter extraction of powdered turmeric was prepared by boiling 100 gm in 1000 ml distilled water over low flame for 15 min, using a heat-stable flask. The content of the flask was allowed to cool for 20 min. After cooling, the supernatant of the mixture was filtered through a Whatman filter (Whatman Clifton, NJ, USA). The filtrate was used to prepare the re quired concentration.
Acute toxicity test (LD 50 ). This was performed on mice and Lorke [10] procedure of LD 50 determi nation was used.
Phytochemical analysis of turmeric. Prelimi nary phytochemical screening of Curcuma longa was carried out at Department of Pharmacognosy, Faculty of Pharmaceutical Science, University of Nigeria Nsukka. Procedures outlined by Trease and Evans [11] were employed for the analyses.
Experimental animals. Forty albino Wistar rats were used for the research. They were obtained from the animal house at Anatomy Department, Universi ty of Nigeria, Enugu campus. The rats were divi ded into 4 groups. Groups: I, II, III and IV, 10 rats per group according to their body weights (200 ± 20 g). The animals were housed in clean steelgauzed cages , under standard condition 28 ± 3 °C and a 12 h light/12 h dark cycle at the animal house at Anato my department, College of medicine, University of Nigeria, Enugu Campus. They were allowed to acclimatize for a period of 2 weeks, with regular clinical examination, before the experiment. The ex perimental protocol was approved by the Institution animal ethics committee of the University of Nigeria Teaching Hospital (UNTH/CSA. 1005/VOL. 18).
Reagents. Total cholesterol (TC) kit, HDL cholesterol kit, triglyceride kit and AST assay kit were purchased from Randox Laboratory (UK); CK MB ELISA kit purchased from Elabscience (Texas, USA); LDH ELISA kit was purchased from MyBio science (San Diego, USA), carbimazole (CBM) from Hovid Inc (Malaysia), atorvastatin (ATOR) obtained from pfizer Inc. (New York, USA). All other reagents were obtained from local suppliers (Enugu, Nigeria) and were of analytical grade.
High-cholesterol diet (HCD). A mixture of 75 g of commercially available cholesterol powder and 9 g of sodium deoxycholate (bile salt added to increase bioavailability) was dissolved in coconut oil and made up with the same solvent to 300 ml to give a stock concentration of 250 mg/ml.
Solutions. 100 tablets of 5mg (i.e. 500 mg) car bimazole were ground to powder, dissolved in dis tilled water and made up to 250 ml in a measuring cylinder to give a stock concentration of 2 mg/ml of carbimazole solution. Atorvastatin (10 tablets of 10 mg) were ground to powder, dissolved in distilled water and made up to 50 ml mark in a volumetric flask to give a stock concentration of 2 mg/ml of atorvastatin solution.
Induction of hyperlipidaemia and cardiac injury. Each experimental rat was coadministered with high cholesterol diet (HCD) at the dose of 2 g/kg and high dose of 60 mg/kg carbimazole solution through an oral gauge every morning for eight weeks.
Experimental design. The rats were divided into 4 groups. group I served as the normal con trol; therefore received no treatment. group II re ceived HCD (2 g/kg, oral), carbimazole (60 mg/kg, oral), with neither extract nor drug for 8 weeks. This served as the toxic (negative) control. group III re ceived HCD, carbimazole and atorvastatin (20 mg/ kg, oral) for 8 weeks. This served as positive control group. group IV received HCD, carbimazole and abbreviation: AECL -aqueous extract of Curcuma longa; ATOR -atorvastatin, TC -total cholesterol; HDLC -high density lipoprotein cholesterol; TG -triglycerides; CK -creatine kinase; LDH -lactate dehydrogenase; AST -aspartate transaminase; CHD -coronary heart disease; CBM -carbimazole; HCD -high cholesterol diet. AECL (200 mg/kg, oral). This served as treatment group.
Blood Sample. After 8 weeks, 6 ml of blood was collected from the axillary vein under chloroform anesthesia, after at least a 12 h overnight fast. The blood was dispensed into a plain container, allowed to clot at room temperature, spun at 5,000 r.p.m for 5 min; serum was separated and cryopreserved for analysis of fasting lipid profile (TC, HDL cholesterol and triglyce ride), and cardiac biomarkers (CKMB, LDH and AST). The hearts were harvested for his topathological studies.
Biochemical analysis. Measurement of serum lipid profile. TC was estimated using cholesterol oxidase method [12] , HDLC was determined using precipitation method [13] and triglyce ride (TG) was estimated using glycerol phosphate oxidase method [14] .
Measurement of cardiac biomarkers. The se rum activities of the creatine kinase isoenzyme, CK MB and LDH were determined using enzyme im munoassay (kit) method [15] . AST was determined using colorimetric method [16] .
histopathological analysis. The excised hearts were processed using the paraffin wax embedding technique, and sectioned at 5 μm. The tissue was stained using haematoxylin and eosin [17] , and ex amined using an Olympus TM light microscope.
Statistical analysis. Data analysis was done using GraphPad prism version 6.0 (GraphPad, San Diego, CA, USA). The results of the biochemical assays were reported as mean ± SEM (standard er ror of mean). Data significance was tested using one way analysis of variance (ANOVA). Results were as sumed significant at P < 0.05.
results and discussion
Acute toxicity studies. LD 50 value of the extract was 7.5 g/kg which indicates that AECL is safe and is not toxic to mice Phytochemical results. The result of the pre liminary phytochemical analysis of Curcuma longa revealed moderate presence of flavoniods, phenolic compound and terpenoid (++); and presence (in trace amount) of alkaloids, glycosides, phytosterols, saponnins and tannins (+). However carbohydrates, reducing sugar, resins, proteins and oils were absent (Table 1) . Table 2 shows the results of serum lipid profile parameters: TC, HDL and TG levels in the diffe rent experimental. From the results, AECL showed sig nificant antihyperlipidaemic potentials (P < 0.05) in comparison with negative control (HCD+CBM). Furthermore, it was observed that the standard drug (atorvastatin) showed much better antihyperlipidae mic effects in the rats than the extract.
In Fig. 1 (A-C) , rats which received (HCD + CBM) alone (negative control) for 8 weeks showed the highest serum CKMB, LDH and AST levels. Data show that coadministration of high cholesterol diet and high dose carbimazole for 8 weeks induced a significant increase in the level of serum CK-MB, LDH and AST in the rats (P < 0.01 or P < 0.05) in comparison with normal control. The positive con trol, atorvastatin, a standard lipidlowering drug was shown to induce a significant decrease in CK-MB, LDH and AST levels in the rats compared with (HCD+CBM) alone (P < 0.01 or P < 0.05). Inter estingly, AECL also significantly decreased CK-MB, LDH and AST levels when compared with (HCD+CBM) alone (P < 0.01 or P < 0.05).
histopathological results. The results are rep resented in Fig. 2 (IIV) . Microscopic examination of the hearts revealed no histopathological alteration in the normal control rats (Fig. 2, I) . Presence of significant distortion and necrosis of the myocardial fibres were observed in the heart of rats treated with oral administration of high cholesterol diet and high dose carbimazole (Fig. 2, II) ; howe ver non-significant de generations were observed in rats administered with (Fig. 2 , III and 2, IV respectively). The hearts of rats in group III and IV showed no signifi cant histological alterations when compared with the normal control group.
In hypercholesterolaemiainduced organ or tis sue model, cholesterol aggravates stressmediated apoptosis [18] . Carbimazole (an antithyroid hor mone drug) has been extensively reported to have toxic effects on delicate organs, such as the testes and other tissues [1922] . Furthermore, hypothyroi dism alters antioxidant defense system in rat [20, 23] . Based on this scientific evidence, a high dose of car bimazole (60 mg/kg, oral), was administered to the rats, for 8 weeks.
Thyroid hormone plays an important role in the regulation of lipid metabolism. Hypothyroidism has been implicated as the cause of hypercholesterolae mia in hypothyroid patients [24] . Thus carbimazole was used in the study to cause a thyroid hormone deficiency which enabled rapid onset of hypercho lesterolaemia in the experimental rats.
Aside inducing hypercholesterolaemia, its cardiotoxic mechanism is not well understood. Al though the mechanism of testicular injury by carbi mazole has been extensively reported to be due to increase in oxidative stress, possibly the coadminis tration of HCD and the high dose carbimazole to the rats for 8 weeks synergistically induced the chronic cardiac muscle effects, observed in this study. There fore, the cardiac muscle changes could be explained on the basis of increased oxidative stress.
In the last few decades, there has been the growing use of herbal medicines because most plants are believed to have medicinal value, turmeric being one of them. The aim of this study was to evaluate the antidyslipidaemic and cardioprotective effects of aqueous extract of Curcuma longa in hypercho lesterolaemic rats; using atorvastatin as a referen ce drug. This present study has shown that AECL prevented dyslipidaemia and cardiomyopathy after the 8 weeks treatment period. Treatment with ator vastatin induced significant antidyslipidaemic effect and cardiac protection. The histopathological results showed concomitant association with the biochemi cal results.
The effects observed in this study could be due to the singular or combined effects of the bioactive phytochemicals present in turmeric extracts, particu larly saponins and phytosterols ( Table 1 ). The hypo cholesterolaemic effects of saponins have long been recognized [25] . Two mechanisms by which sapo nins can affect cholesterol metabolism were suggested [26] . 1) Some saponins with particularly defined structural characteristics form insoluble complexes with cholesterol. When this complex-forming pro cess occurs in the gut, it inhibits intestinal absorp tion of both endogenous and exogenous cholesterol. 2) Saponins can interfere with the enterohepatic circulation of bile acids by forming mixed micelles. The reabsorption of bile acids from the terminal ileum is effectively blocked [27] . In animal models, soya saponins were found to significantly reduce se rum TC, lowdensity lipoproteincholesterol (LDL C), TG concentrations, and to increase highdensity lipoproteincholesterol (HDLC) levels in rats [28] . Phytosterols that have long been known to reduce intestinal cholesterol absorption, lead to decrease blood LDLcholesterol levels and lower cardiovascu lar disease risk. In the 1950's, phytosterols from soy beans were found to lower serum cholesterol level [29] . Since then, the cholesterol-lowering effects of phytosterols have been extensively demon strated in both humans and animals [30] .
Hyperlipidaemia and oxidative stress following the hypercholesterolaemic diet could be prevented by endogenous and exogenous antioxidants [31] . The protection by artovastatin as observed in the present study may be due to the anti-inflammatory and an tioxidant properties of atorvastatin, which has been reported to have a potential protective effect on kid ney function [32] .
T a b l e 2. Comparison of serum lipid profile of treated groups with negative controls
Values given as mean ± SEM. **P ˂ 0.01 or *P ˂ 0.05 is significant when (HCD + CBM) is compared with all other groups Recently, the role of diet in human health has received considerable attention. Several epidemio logical studies have indicated that a high intake of plant products is associated with a reduced risk of a number of chronic diseases, such as atherosclerosis and cancer [33] . The consumption of plant products was shown to reduce hypercholesterolaemia, oxida tive stress, homocystienaemia, endothelia dysfunc tion and blood pressure [34, 35] . These beneficial effects have been partly attributed to the compound which possesses antioxidation. Tumeric is rich in both anti-inflammatory and antioxidant phytochemi cals such flavonoids.
The implication of this study is that turmeric is cardioprotective and its consumption should be en couraged in families. Further research on effects of different extracts of turmeric should be evaluated for more potential health benefits. Food and drug indus tries should harness the protective property of tur meric for the general benefit of mankind. Attention should be focused on the cardioprotective effects of turmeric against coronary heart disease.
This study showed that the aqueous extract of Curcuma longa has effect on the lipid metabo lism and prevents cardiomyopathy in albino rats fed a high cholesterol diet and high dose carbimazole. Therefore, the alterations in the serum lipid by the aqueous extract of Curcuma longa may not predis pose the heart to atherosclerosis or its associated car diomyopathy or infarction.
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Funding. This research did not receive any specific grant from any funding agency. Коронарний атеросклероз асоціюється з кардіоміопатією в пацієнтів у всьому світі. Рі вень серцево-судинних ризиків дуже високий в усьому світі, а лікування серцевих захворювань стає величезним фінансовим тягарем, тому про філактика серцевих захворювань є кращою та ефективною опцією. Метою дослідження було оцінити кардіопротекторну дію водного екстракту Curcuma longa (AECL) в щурів із гіперхолес теринемією. В експерименті використовували 40 щурів, випадковим чином розділених на чотири групи (I, II, III, IV) -по 10 щурів в кожній групі. Група I (нормальний контроль) не отримувала ніякого лікування. Групи II-IV отримували дієту з високим вмістом холестеролу (2000 мг/кг, перорально) і високу дозу карбімазолу (60 мг/кг, перорально) один раз на день протягом 8 тиж нів для індукції гіперхолестеринемії. Група II служила токсичним (негативним) контролем. Група III (позитивний контроль) отримувала лі кування аторвастатином (20 мг/кг, перорально). Група IV (група лікування) отримувала AECL (200 мг/кг) один раз на день протягом 8 тижнів. Біохімічний аналіз проводили стандартними методами. Визначали такі біохімічні показни ки: параметри ліпідного профілю (загальний холестерол, холестерол ліпопротеїнів високої щільності, тригліцероли) і біомаркери серця (ак тивність креатинкінази, лактатдегідрогенази і аспартат трансамінази). Серця було використано для гістопатологічних досліджень. Показано, що AECL сприяє гіполіпідемії, стабілізує біохімічні маркери серця (P < 0,05 або P < 0,01); захищає волокна серцевих м'язів від ушкоджень. Одержа ні результати дозволяють припустити, що екс тракт Curcuma longa має кардіопротекторний потенціал і може бути використаний для запо бігання ушкодження міокарда, спричиненого гіперхолестеринемією.
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